Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis
Open Access
- 11 February 2014
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 84
Abstract
While microRNA (miRNA) expression is known to be altered in a variety of human malignancies contributing to cancer development and progression, the potential role of miRNA dysregulation in malignant mast cell disease has not been previously explored. The purpose of this study was to investigate the potential contribution of miRNA dysregulation to the biology of canine mast cell tumors (MCTs), a well-established spontaneous model of malignant mast cell disease.Keywords
This publication has 55 references indexed in Scilit:
- Comparison of non-coding RNAs in human and canine cancerFrontiers in Genetics, 2013
- Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunityBrain, 2011
- KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferationBlood, 2011
- MiR‐9 downregulates CDX2 expression in gastric cancer cellsInternational Journal of Cancer, 2011
- AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated KitBlood, 2010
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature Cell Biology, 2010
- Mast cell tryptases and chymases in inflammation and host defenseImmunological Reviews, 2007
- MAP17 overexpression is a common characteristic of carcinomasCarcinogenesis, 2007
- MAP17 enhances the malignant behavior of tumor cells through ROS increaseCarcinogenesis, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001